INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving Humana Inc. following a lawsuit filed by the U.S. Department of Justice alleging illegal kickbacks related to Medicare Advantage plans [1][3]. Group 1: Investigation and Legal Actions - Pomerantz LLP is representing investors of Humana Inc. in an investigation concerning possible securities fraud or unlawful business practices by the company and its officers [1]. - The U.S. Department of Justice filed a False Claims Act complaint against Humana and other health insurance companies, alleging that from 2016 to 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [3]. - Following the DOJ's lawsuit announcement, Humana's stock price decreased by $6.20 per share, or 2.36%, closing at $256.04 on May 1, 2025 [3]. Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for victims of securities fraud and corporate misconduct [4].